Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wagenmann

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Allergologie Select|April 12, 2021
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergologie Select|September 17, 2021
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
International Forum of Allergy & Rhinology|July 3, 2026
Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps-Are We Comparing Apples With Oranges?Marjolein Cornet, Peter W Hellings, Martin Desrosiers, et al.
American Journal of Otolaryngology|January 31, 2025
Baseline disease characteristics by surgery history among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the global AROMA registryShigeharu Fujieda, Jayant M Pinto, David W Jang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2024
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment ComparisonClaire Hopkins, Joseph K Han, Wytske Fokkens, et al.
Clinical & Translational Immunology|February 1, 2023
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Stella E Lee, Russell A Settipane, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 18, 2023
Current situation of allergological health care at German hospitalsMoritz Maximilian Hollstein, Anna Schober, Regina Treudler, et al.
Anticancer Research|March 2, 2018
Mutational and Functional Analysis of <i>FANCB</i> as a Candidate Gene for Sporadic Head and Neck Squamous Cell CarcinomasMarcel F Glaas, Constanze Wiek, Linda-Maria Wolter, et al.
International Archives of Allergy and Immunology|April 4, 2023
Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in GermanyAnna Katharina Schober, Moritz Maximilian Hollstein, Regina Treudler, et al.
The Journal of Allergy and Clinical Immunology|November 23, 2020
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and managementClaus Bachert, Joe K Han, Martin Wagenmann, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Allergologie Select|April 12, 2021
COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA)Oliver Pfaar, Ludger Klimek, Eckard Hamelmann, et al.
Allergologie Select|September 17, 2021
COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)Ludger Klimek, Oliver Pfaar, Eckard Hamelmann, et al.
International Forum of Allergy & Rhinology|July 3, 2026
Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps-Are We Comparing Apples With Oranges?Marjolein Cornet, Peter W Hellings, Martin Desrosiers, et al.
American Journal of Otolaryngology|January 31, 2025
Baseline disease characteristics by surgery history among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in the global AROMA registryShigeharu Fujieda, Jayant M Pinto, David W Jang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 26, 2024
Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis With Nasal Polyposis: An Indirect Treatment ComparisonClaire Hopkins, Joseph K Han, Wytske Fokkens, et al.
Clinical & Translational Immunology|February 1, 2023
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Stella E Lee, Russell A Settipane, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 18, 2023
Current situation of allergological health care at German hospitalsMoritz Maximilian Hollstein, Anna Schober, Regina Treudler, et al.
Anticancer Research|March 2, 2018
Mutational and Functional Analysis of <i>FANCB</i> as a Candidate Gene for Sporadic Head and Neck Squamous Cell CarcinomasMarcel F Glaas, Constanze Wiek, Linda-Maria Wolter, et al.
International Archives of Allergy and Immunology|April 4, 2023
Limited Reimbursement and Underuse of Digital Healthcare Concepts Are Major Barriers to Clinical Allergological Care in GermanyAnna Katharina Schober, Moritz Maximilian Hollstein, Regina Treudler, et al.
The Journal of Allergy and Clinical Immunology|November 23, 2020
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and managementClaus Bachert, Joe K Han, Martin Wagenmann, et al.
Pageof 9